Health, hope, and reintegration: How medical cannabis supports the economy and society

Since legalisation in November 2018, the economic benefits of medical cannabis in the UK have been (debatably) as impactful as the clinical benefits it offers patients across the British Isles. 

For many patients, improved health has meant much more than just relief from symptoms, and the economy is coming along for the ride. 

Medical cannabis has opened the door back into work, education, family life, and community. People who once felt cut off by pain, anxiety, sleep disorders, or any number of other health concerns that medical cannabis has been shown to help with are now able to take part again - whether that means returning to employment, studying, or simply joining time with their friends at the pub or a concert. 

This reintegration is a form of economic participation in itself, adding energy and value that numbers alone can’t capture.

Medical cannabis is fuelling growth across the UK economy

Domestic medical cannabis cultivation and supply have created new roles in farming, compliance, logistics, and patient support, with medical cannabis jobs UK now spanning every part of the chain. Clinics themselves are major employers: Releaf has grown from a staff of 20 in February 2023 to more than 100 here in September 2025, and we are just one of many private UK medical cannabis clinics contributing to this growth.

The UK has long been one of the leading exporters of medical cannabis, though this has largely been through licensed pharmaceutical products such as Sativex and Epidiolex rather than dried flower. Even so, these exports strengthen the UK’s global position while the domestic industry develops a broader base. As we move forward, stigma and misinformation (while still quite prevalent) are slowly being replaced by clinical understanding and wider general acceptance. 

What are the economic benefits of medical cannabis in the UK?

Since 2018, medical cannabis has more than edged its way into the UK health economy. The Prohibition Partners 2025 White Paper places the UK medical cannabis market second in Europe, with 50,000 to 60,000 patients already in treatment and as many as 80,000 expected by the year’s end.

Market value was forecast at €269 million. That figure is already high enough to place the UK fifth worldwide, with analysts expecting it to move ahead of Israel and Canada within the next year. For a market that has really only started to blossom in the past 18 months, the growth is somewhat staggering. 

This growth has been pushed mostly through private medical cannabis clinic prescribing and steady imports. Portugal, Canada, and Spain have been the largest suppliers, though domestic production has begun with companies like Glass Pharms®, taking the lead.

The economic benefits of this growth include:

• New jobs creation
• Domestic investment through UK based producers
• Treasury benefits, with modelling suggesting up to £1.5 billion annually under broader reform.
• NHS savings of up to £4 billion a year if prescribed more widely for chronic pain alone.
• Greater economic participation as patients return to work, study and community life.
• Reduced justice system costs, with fewer arrests and prosecutions for cannabis use shifting resources away from enforcement.

How does the medical cannabis sector support jobs and UK businesses?

The Prohibition Partners 2025 report does give clear numbers on how many jobs currently exist (although an earlier report put the number estimate at 96,000 for 2024). 

And cultivation is only the start. 

Crops must be tested in laboratories, handled by logistics teams, and dispensed by pharmacies. Patient services guide people through consultations and repeat prescriptions, while marketing and education staff work within strict rules to raise awareness. 

Each of these steps adds employment, linking agriculture, science, health, and communication. There are teams managing compliance, pharmacy, technology, logistics and patient care.  

In addition, clinics depend on board members, compliance officers and marketers, along with the many other roles that keep a business running day to day. Awareness has to be built within strict regulations, and digital teams ensure that online platforms remain reliable, so patients can book, consult and reorder with ease. These positions may not attract the same attention as cultivation, but they are central to the way the system functions.

The patient journey is shaped by specialists at every step

Only doctors on the GMC Specialist Register can prescribe medical cannabis in the UK, and Releaf’s world-class clinical team covers almost every relevant field. Neurologists, psychiatrists, oncologists, and pain consultants bring years of experience into a new area of practice.

They are supported by GPs, nurses, patient support teams and service staff who guide people through eligibility checks, consultations, and follow-up care. These are the people patients speak to most often, and their work turns a prescription into a lasting relationship with care.

This highlights that medical cannabis employment stretches far beyond the grow room. From farming to online services, and from compliance to patient-facing care, the sector is already generating work across a wide sweep of the UK economy.

NHS cost savings are part of the picture

The clearest economic case in the UK relates to chronic pain, with one study suggesting that wider prescribing could save the NHS up to £4 billion each year. But pain is only one of several groups for which medical cannabis can be prescribed legally.

Patients may also qualify under psychiatric and mental health, sleep disorders, neurological conditions, women’s health issues, gastroenterological conditions, and cancer support. Each represents its own area of need and its own potential for NHS savings.

The more these conditions are managed through medical cannabis, the fewer prescriptions are written for high-cost drugs, with potentially fewer hospital admissions, and less pressure falling on frontline clinicians. The economic benefit comes not only through money saved, but also through capacity freed inside the NHS system.

How do patients reintegrate into work and society with medical cannabis?

When people are given the tools to manage their health with treatments that suit them, the results are rarely limited to symptom relief. For many patients, medical cannabis opens the door back into ordinary life.

Some return to formal work, contributing taxes and skills that had been left dormant. Others rejoin education, continue studies that had been interrupted, or take on training that once felt impossible.

Every day life carries its own economic value

Reintegration in this sense is its own form of economic participation. It is money spent in cafés and shops, tickets bought for concerts and cinemas, and holidays finally taken once more. It is also the value of people who feel well enough to support relatives, volunteer locally, or simply show up again in the lives of those around them.

Every pub dinner, school event, or family outing becomes part of the social impact of medical cannabis. These small acts may not be counted in national accounts, but they could be substantial in strengthening local economies and communities.

This is the soft economy at work: the unrecorded but very real flow of value created when people are well enough to take part. Medical cannabis patient reintegration is not only about jobs regained but also about lives rebuilt, and both carry weight when we consider the true benefits of treatment.

What does Releaf’s leadership say about the wider impact of medical cannabis?

Releaf’s CEO, Tim Kirby, explains why the debate must go beyond clinics and prescriptions, and into the broader economic and societal impact:

“Medical cannabis is not just a clinical question, it is an economic and societal one. When you replace trial-and-error with consistent, quality-controlled supply, people sleep, work, and reconnect. We see it every day in our outcomes data and in our patients’ lives. Integrated technology, proper dosage forms, and a domestic, medically-led supply chain reduce pressure on the NHS while widening access for cannabis-naive demographics. That is how you move beyond stigma to measurable gains in quality of life and participation in the economy.”

How do patients describe the impact of medical cannabis?

Beyond the numbers, the clearest picture of medical cannabis patient reintegration comes from the voices of patients themselves. Check out our Patient Story section for the full accounts, but here are a few excerpts that show what treatment can mean in day-to-day life.

Paul

“There’s so much more freedom than before I began treatment with Releaf. One of the best parts is spending more time with my grandkids.

We’ve started new projects together, like fixing up the garden. We’ve got cabbages, potatoes, peas, a fig tree and an apple tree, and we’re planning raised beds to make it easier. The kids love helping, and we’ve even collected shells from the beach to plaster into a wall.

I love growing things from seed, even just a chilli pepper. It feels good to see something grow because of your own effort. The treatment has improved my quality of life completely.

I’m getting out more, seeing the grandkids more, and enjoying simple things like the summer holidays. We’ve got an eight by four foot pool in the garden, and we all jump in together. That’s the kind of joy I’d missed before.”

David 

“On a day-to-day basis, it’s made a huge difference. Before, I’d often feel very withdrawn. I didn’t want to socialise, I’d avoid talking to people. I just kept to myself. Since starting the treatment, that’s completely changed. I want to go out. I want to talk to people. I can’t stop talking. That whole side of things has shifted.

I’d say the biggest change is that I don’t wake up with fear any more. I used to open my eyes and feel dread, not knowing how the day would go. Now I get up, and I know it’s going to be a good day. I’ve got good medicine. I feel calm. I feel like myself.”

Lisa

“Pain-free days are the norm now, definitely, and I can switch off at night, which has been a huge benefit…

I’m still getting the same amount of sleep, but it’s much better quality, and that’s helped with my energy levels. I’m finally able to focus on myself instead of constantly thinking about my pain. When I was suffering from heavy pain all the time, it was really hard to fully focus on anything else.

In terms of work, I am three years into my most recent project now, and it’s about to wrap up. I honestly don’t think I could have done it without medical cannabis.

I’m looking forward to what's next!”

What is the true value of medical cannabis?

The UK still lacks detailed data on the economic and social impact of medical cannabis. That gap makes it harder to move debate beyond stigma, but the evidence we do have points towards benefits that ripple far beyond the clinic and patient.

Releaf’s role is to keep this conversation open. 

By showing how treatment restores lives and strengthens society, we aim to place medical cannabis in its rightful context: a health intervention with economic and human value.

If you are considering treatment yourself, the first step is simple. Head to the Releaf medical cannabis eligibility checker.